2022 Q4 Form 20-F Financial Statement

#000106299323008220 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $160.1K $535.2K -$120.00
YoY Change -133491.67% 41.82% -100.05%
% of Gross Profit
Research & Development $220.6K $981.6K $460.8K
YoY Change -52.13% -39.05% 84.32%
% of Gross Profit
Depreciation & Amortization $80.03K $188.4K $27.30K
YoY Change 193.15% 8.46% -9.0%
% of Gross Profit
Operating Expenses $460.7K $1.705M $488.0K
YoY Change -5.59% -21.12% -2.41%
Operating Profit -$1.705M
YoY Change -21.12%
Interest Expense -$8.550K -$577.7K $7.400K
YoY Change -215.54% -300.51% -98.88%
% of Operating Profit
Other Income/Expense, Net $460.1K $3.270M $48.99K
YoY Change 839.25% -20.83% -110.21%
Pretax Income -$9.080K $1.565M -$642.6K
YoY Change -98.59% -23.51% 100.81%
Income Tax $200.0K $800.0K $200.0K
% Of Pretax Income 51.12%
Net Earnings -$164.7K $631.8K -$739.5K
YoY Change -77.73% -24.43% 71.98%
Net Earnings / Revenue
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.00 $0.01 -$15.84K
COMMON SHARES
Basic Shares Outstanding 46.45M shares 46.54M shares
Diluted Shares Outstanding 48.82M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.278M $9.278M $8.049M
YoY Change 15.28% 15.28% 18.36%
Cash & Equivalents $5.781M $5.781M $4.675M
Short-Term Investments $3.497M $3.497M $3.373M
Other Short-Term Assets $104.8K
YoY Change 1.54%
Inventory $795.9K $795.9K $975.3K
Prepaid Expenses $104.8K
Receivables $104.8K $104.8K $103.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.18M $10.18M $9.127M
YoY Change 11.52% 11.52% 17.92%
LONG-TERM ASSETS
Property, Plant & Equipment $671.4K $1.406M $1.335M
YoY Change -49.69% 5.34% 2.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $296.3K $296.3K $296.3K
YoY Change 0.0% 0.0% -1.23%
Total Long-Term Assets $1.702M $1.702M $1.631M
YoY Change 4.37% 4.37% 1.93%
TOTAL ASSETS
Total Short-Term Assets $10.18M $10.18M $9.127M
Total Long-Term Assets $1.702M $1.702M $1.631M
Total Assets $11.88M $11.88M $10.76M
YoY Change 10.44% 10.44% 15.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.307M $1.307M $1.029M
YoY Change 27.02% 27.02% 254.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.407M $1.407M $1.122M
YoY Change 25.32% 25.32% 161.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.407M $1.407M $1.122M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.407M $1.349M $931.3K
YoY Change 51.05% 44.81% 746.63%
SHAREHOLDERS EQUITY
Retained Earnings -$21.35M -$21.98M
YoY Change -2.87% -3.66%
Common Stock $46.45K $46.69K
YoY Change -0.52% -0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.892K $13.29K
YoY Change -48.16% 173.71%
Treasury Stock Shares
Shareholders Equity $10.53M $10.53M $9.827M
YoY Change
Total Liabilities & Shareholders Equity $11.88M $11.88M $10.76M
YoY Change 10.44% 10.44% 15.18%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$164.7K $631.8K -$739.5K
YoY Change -77.73% -24.43% 71.98%
Depreciation, Depletion And Amortization $80.03K $188.4K $27.30K
YoY Change 193.15% 8.46% -9.0%
Cash From Operating Activities -$321.5K $1.528M -$1.863M
YoY Change -82.75% 129.46% 37.02%
INVESTING ACTIVITIES
Capital Expenditures $215.2K $259.6K -$32.21K
YoY Change -768.12% -227.62% -140.26%
Acquisitions
YoY Change
Other Investing Activities $44.59K
YoY Change -109.22%
Cash From Investing Activities -$215.2K -$259.6K -$32.21K
YoY Change 568.12% 27.62% -140.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $163.1K $22.43K
YoY Change -168.37% -132.04%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.73K -$163.1K 22.43K
YoY Change -237.0% -31.63% -132.04%
NET CHANGE
Cash From Operating Activities -321.5K $1.528M -1.863M
Cash From Investing Activities -215.2K -$259.6K -32.21K
Cash From Financing Activities -30.73K -$163.1K 22.43K
Net Change In Cash -567.4K $1.106M -1.873M
YoY Change -69.71% 393.45% 38.76%
FREE CASH FLOW
Cash From Operating Activities -$321.5K $1.528M -$1.863M
Capital Expenditures $215.2K $259.6K -$32.21K
Free Cash Flow -$536.7K $1.269M -$1.831M
YoY Change -70.69% 45.92% 27.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4451256 usd
CY2022Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
3239782 usd
CY2021Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
3268618 usd
CY2020Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
1977477 usd
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
2345984 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
104791 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
103204 usd
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
100605 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
841978 usd
CY2020Q4 us-gaap Assets Current
AssetsCurrent
7739823 usd
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
296322 usd
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
570375 usd
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
734422 usd
CY2020Q4 us-gaap Assets
Assets
9340942 usd
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
286422 usd
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
140397 usd
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
426819 usd
CY2020Q4 us-gaap Liabilities
Liabilities
426819 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46817017 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46817017 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
46817 usd
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31998045 usd
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4857 usd
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22813141 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9226864 usd
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-312741 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8914123 usd
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9340942 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
143407 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55972 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45589 usd
CY2022 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
0 usd
CY2021 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
0 usd
CY2020 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
-137313 usd
CY2020 xtgr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
334132 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94929 usd
CY2022 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
6892 usd
CY2022 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
0 usd
CY2021 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
0 usd
CY2020 xtgr Change In Fair Value Warrant Derivative Liability
ChangeInFairValueWarrantDerivativeLiability
-137313 usd
CY2022 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
2149341 usd
CY2021 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
2537144 usd
CY2020 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1378637 usd
CY2022 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
2193935 usd
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
2053292 usd
CY2020 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1562517 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1587 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2599 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-76836 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48822024 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4451256 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2586000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2381000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2636000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48925574 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49589430 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46542900 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46779574 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46095232 shares
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3772568 usd
CY2020Q4 us-gaap Debt Securities
DebtSecurities
3772568 usd
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
2345984 usd
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
296322 usd
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
2345984 usd
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
4451256 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Concentration of credit risk</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial instrument which potentially subjects the Company to concentration of credit risk is cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. As of December 31, 2022, the Company held $5,653,644 (December 31, 2021 - $4,578,256, December 31, 2020 - $4,305,287) in low-risk cash and money market funds which are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. <span style="color:#212121;background-color:#ffffff">The company has contracted to sell all its recovered gold through a licensed exporter in Ghana.</span></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#212121;background-color:#ffffff">The Company uses one smelter to process its raw gold. Ownership of the gold is transferred to the smelting company at the mine site. </span>The Company has not experienced any losses from this sole sourced smelter and believes it is not exposed to any significant risks on its gold processing.</span></span></p> </div>
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4305287 usd
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
2345984 usd
CY2021 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-211018 usd
CY2020Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
1977477 usd
CY2020 xtgr Trading Securities Change In Unrealized Holding Gain Or Loss
TradingSecuritiesChangeInUnrealizedHoldingGainOrLoss
368507 usd
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
2345984 usd
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2582163 usd
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2011788 usd
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
570375 usd
CY2022Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
1607729 usd
CY2021Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
1607729 usd
CY2020Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
1607729 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
8133 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
8133 usd
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
8133 usd
CY2022Q4 xtgr Mineral Properties Option Payments Received
MineralPropertiesOptionPaymentsReceived
881440 usd
CY2021Q4 xtgr Mineral Properties Option Payments Received
MineralPropertiesOptionPaymentsReceived
881440 usd
CY2020Q4 xtgr Mineral Properties Option Payments Received
MineralPropertiesOptionPaymentsReceived
881440 usd
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
734422 usd
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
734422 usd
CY2019Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
158914 usd
CY2020 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
18517 usd
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0 usd
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
140397 usd
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
140397 usd
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2615000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
795939 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
975270 usd
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
841978 usd
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
255000 shares
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
118750 cad
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94929 usd
CY2020 xtgr Number Of Common Stock Shares Issued For Exercise Of Warrants
NumberOfCommonStockSharesIssuedForExerciseOfWarrants
885000 shares
CY2020 xtgr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
0.5
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
442500 cad
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
334132 usd
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
346500 shares
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94575 cad
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71912 usd
CY2020 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
5200 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
534000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.8
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
346500 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.21
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
166500 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.31
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2636000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2636000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.35
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1666776 usd
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1250000 shares
CY2020Q4 xtgr Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.5
CY2021 xtgr Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2020 xtgr Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0 shares
CY2020 xtgr Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 xtgr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2021 xtgr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2020 xtgr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
885000 shares
CY2019Q4 xtgr Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.5
CY2022 xtgr Class Of Warrant Or Right Expirations In Period
ClassOfWarrantOrRightExpirationsInPeriod
0 shares
CY2021 xtgr Class Of Warrant Or Right Expirations In Period
ClassOfWarrantOrRightExpirationsInPeriod
0 shares
CY2020 xtgr Class Of Warrant Or Right Expirations In Period
ClassOfWarrantOrRightExpirationsInPeriod
365000 shares
CY2019Q4 xtgr Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.5
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2021Q4 xtgr Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1564849 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2303646 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2155241 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
60256 usd
CY2022 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
11500 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
xtgr-20221231_cal.xml Edgar Link unprocessable
0001062993-23-008220-index-headers.html Edgar Link pending
0001062993-23-008220-index.html Edgar Link pending
0001062993-23-008220.txt Edgar Link pending
0001062993-23-008220-xbrl.zip Edgar Link pending
exhibit12-1.htm Edgar Link pending
exhibit12-2.htm Edgar Link pending
exhibit13-1.htm Edgar Link pending
exhibit13-2.htm Edgar Link pending
exhibit99-1.htm Edgar Link pending
exhibit99-1xz001.jpg Edgar Link pending
exhibit99-1xz002.jpg Edgar Link pending
exhibit99-1xz003.jpg Edgar Link pending
exhibit99-1xz004.jpg Edgar Link pending
exhibit99-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form20f.htm Edgar Link pending
form20fxz001.jpg Edgar Link pending
form20fxz002.jpg Edgar Link pending
form20fxz003.jpg Edgar Link pending
form20fxz004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
form20f_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xtgr-20221231.xsd Edgar Link pending
xtgr-20221231_def.xml Edgar Link unprocessable
xtgr-20221231_lab.xml Edgar Link unprocessable
xtgr-20221231_pre.xml Edgar Link unprocessable